Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00579917 · ClinicalTrials.gov registry record

Behavioral Intervention For BMT/SCT Survivors

A clinical trial, sponsored by Memorial Sloan Kettering Cancer Center.

Completed
Registry status
133
Enrollment target

NCT00579917: Completed study, sponsored by Memorial Sloan Kettering Cancer Center.

NCT00579917 is a clinical trial that has completed, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 133 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT00579917 has completed, sponsored by Memorial Sloan Kettering Cancer Center.

COMPLETED
Registry status
133 participants
Enrollment target

Study Summary

The purpose of this study is to understand how to help survivors of bone marrow transplant and stem cell transplant (BMT/SCT) with emotional distress. BMT/SCT has become a more common type of treatment for cancer or hematological disorder (blood disease). For this reason, there is concern that adjustment after treatment may be difficult for many persons. We have found that about 25% of BMT/SCT survivors still feel anxious and distressed about their illness and its treatment after at least one year following transplant. This study is one of the first to study the impact of counseling on BMT/SCT survivors. The study is being carried out at Memorial Sloan-Kettering Cancer Center, Mount Sinai Medical Center, and Hackensack University Medical Center.

Interventions

  • BEHAVIORAL Cognitive Behavioral Therapy: Questionnaires
  • BEHAVIORAL Usual Care: Questionnaires

Trial Details

FieldValue
Enrollment Target 133 participants
Start Date 2005-01
Est. Completion 2008-12
Memorial Sloan Kettering Cancer Center

1,884 total trials

What the finished NCT00579917 record still lists

NCT00579917 is an observational study that tracks outcomes without assigning an intervention. The registered 133 participants enrollment target is mid-sized for trials with a published cap.

The record links to 0 conditions, and to 2 interventions - of which Cognitive Behavioral Therapy: Questionnaires is the first listed.

NCT00579917 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00579917 about?

NCT00579917 is a clinical study titled "Behavioral Intervention For BMT/SCT Survivors". The purpose of this study is to understand how to help survivors of bone marrow transplant and stem cell transplant (BMT/SCT) with emotional distress. BMT/SCT has become a more common type of treatment for cancer or hematological disorder (blood disease). For this reason, there is concern that adjus...

What is the current status of trial NCT00579917?

This trial is currently completed. The enrollment target is 133 participants. The study started on 2005-01. Estimated completion is 2008-12.

What interventions are being tested in trial NCT00579917?

The interventions under investigation include: Cognitive Behavioral Therapy: Questionnaires (BEHAVIORAL), Usual Care: Questionnaires (BEHAVIORAL).

Who is sponsoring clinical trial NCT00579917?

This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04276870 · 133 participants · Phase 2

    Orphan Indications for CD19 Redirected Autologous T Cells

  • NCT04671771 · 133 participants · NA

    A Study to Evaluate the Safety and Effectiveness of the InnAVasc Arteriovenous Graft for Hemodialysis Access in Patients With End-Stage Renal Disease

  • NCT05610085 · 133 participants · Phase 2

    A Dose Escalation Study of Levetiracetam in the Treatment of Neonatal Seizures

  • NCT06206486 · 133 participants

    The Gut Microbiome and Serum Metabolites As a Biological Mechanism Underlying Pain in Kidney Transplantation

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00579917, the US trial registry maintained by the National Library of Medicine. NCT00579917 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.